Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Athanasios Pseftogas"'
Autor:
Dimitrios Giakoustidis, Athanasios Apostolos Gargavanis, Kali Makedou, Thomas Goulopoulos, Alexander Giakoustidis, George Mosialos, Hara Afaloniati, Theofilos Poutahidis, Alexandros Hardas, Stavros Iliadis, Katerina Angelopoulou, Athanasios Pseftogas, Vasileios Papadopoulos, Apostolos Papalois
Publikováno v:
OncoTargets and Therapy. 13:5575-5588
Background Hepatocellular carcinoma (HCC) is a frequently diagnosed cancer and a leading cause of cancer-related death worldwide. Its rapid progression, combined with the limited treatment options at late stages, imposes the need for early detection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff81ae0fdb84cd5884c556ca8016e596
https://doi.org/10.2147/ott.s250233
https://doi.org/10.2147/ott.s250233
Autor:
Athanasios Pseftogas
Η πρωτεΐνη CYLD είναι μία αποουβικιτινάση η οποία δρα ως αρνητικός ρυθμιστής των μονοπατιών του NF-κB, της JNK και του p38. Η CYLD είναι κυρίως μία
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0329e58f57120a3915c7b5fae2284793
https://doi.org/10.12681/eadd/42749
https://doi.org/10.12681/eadd/42749
Autor:
Christos Gonidas, Eudoxia Hatzivassiliou, Alexander Hardas, Theofilos Poutahidis, Chrysanthi Ainali, Xaralabos Varelas, Joseph G. Kern, Athanasios Pseftogas, Dimitra Dafou, Anastasia Tsingotjidou, Konstantinos Xanthopoulos, Emmanuel Panteris, George Mosialos
Publikováno v:
Cancers
Cancers, Vol 12, Iss 2047, p 2047 (2020)
Volume 12
Issue 8
Cancers, Vol 12, Iss 2047, p 2047 (2020)
Volume 12
Issue 8
Downregulation of the cylindromatosis (CYLD) tumor suppressor has been associated with breast cancer development and progression. Here, we report a critical role for CYLD in maintaining the phenotype of mammary epithelial cells in vitro and in vivo.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9d359a6bc9a2de4dba2ecbbc53b335a
http://europepmc.org/articles/PMC7466024
http://europepmc.org/articles/PMC7466024
Publikováno v:
The International Journal of Biochemistry & Cell Biology. 82:49-56
Several studies have implicated the downregulation of the tumor suppressor Cyld expression in breast cancer development. However, the mechanisms that regulate Cyld expression in mammary epithelial cells are largely unknown. In order to investigate th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::473dfe0f664dd9bb8251fd29a51a0729
https://doi.org/10.1016/j.biocel.2016.11.011
https://doi.org/10.1016/j.biocel.2016.11.011
Autor:
George Mosialos, Konstantinos Xanthopoulos, Theofilos Poutahidis, Eudoxia Hatzivassiliou, Konstantinos Teliousis, Demetrios N Karatzas, Dimitris L. Kontoyiannis, Panorea Kotantaki, Athanasios Pseftogas
Publikováno v:
Cellular Oncology. 39:287-293
CYLD is a tumor suppressor that has been linked to the development of various human malignancies, including colon cancer. The tumor-suppressing function of CYLD is associated with its deubiquitinating activity, which maps to the carboxyl-terminal reg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edf446ecd9702ee317c3392b95ac44f2
https://doi.org/10.1007/s13402-016-0279-3
https://doi.org/10.1007/s13402-016-0279-3
Autor:
Paul Hadweh, Claire Psyllaki, George Mosialos, Eudoxia Hatzivassiliou, Konstantinos Xanthopoulos, Dimitra Dafou, Athanasios Pseftogas, Timoklia Orfanidou
Publikováno v:
Anticancer research. 37(7)
Background/aim The cylindromatosis tumor suppressor (CYLD) has been implicated in the inhibition of human breast cancer development by virtue of the poor prognosis of patients with down-regulated CYLD expression. In order to investigate the mechanism
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e25b60e2cb468706a10a282a97cb997
https://pubmed.ncbi.nlm.nih.gov/28668838
https://pubmed.ncbi.nlm.nih.gov/28668838